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Optimization of ClpXP activity 
and protein synthesis in an E. coli 
extract-based cell-free expression 
system
Xinying Shi, Ti Wu  , Christian M. Cole, Neal K. Devaraj & Simpson Joseph
Protein degradation is a fundamental process in all living cells and is essential to remove both damaged 
proteins and intact proteins that are no longer needed by the cell. We are interested in creating 
synthetic genetic circuits that function in a cell-free expression system. This will require not only an 
efficient protein expression platform but also a robust protein degradation system in cell extract. 
Therefore, we purified and tested the activity of E. coli ClpXP protease in cell-free transcription-
translation (TX-TL) systems that used E. coli S30 cell extract. Surprisingly, our studies showed that 
purified ClpXP added to the TX-TL system has very low proteolytic activity. The low activity of ClpXP 
was correlated with the rapid consumption of adenosine triphosphate (ATP) in cell extract. We improved 
the activity of ClpXP in cell extract by adding exogenous ATP and an energy regeneration system. We 
then established conditions for both protein synthesis, and protein degradation by ClpXP to occur 
simultaneously in the TX-TL systems. The optimized conditions for ClpXP activity will be useful for 
creating tunable synthetic genetic circuits and in vitro synthetic biology.
Protein degradation is an essential process in all living cells that is used to remove damaged or misfolded pro-
teins and to tune gene expression by temporally controlling the concentration of regulatory proteins. In bacteria, 
targeted protein degradation is carried out by the AAA+ family of proteases, which include ClpAP, ClpXP, FtsH, 
HslUV (also known as ClpYQ), or Lon1,2. The mechanism of ClpXP is well understood and therefore ClpXP 
protein degradation is widely used in in vitro synthetic biology3–5. The ClpXP protease is an oligomer formed by 
6 identical ClpX proteins, that form a hexameric ring, and 14 identical ClpP proteins, which form a double-ring 
structure6,7. The overall structure of the ClpXP protease resembles a barrel with a central axial pore. The ClpX 
protein uses ATP binding and hydrolysis to unfold protein substrates and translocate the denatured polypeptide 
through the central pore to the proteolytic chamber formed by the ClpP protease1,2. Most protein substrates that 
are targeted for degradation have a tag sequence that is recognized by a specific protease. In the case of ClpXP, 
protein substrates that have five distinct motifs (three located at the N-terminus and two at the C-terminus) are 
targeted for degradation8. Additionally, the E. coli ClpXP protease degrades proteins that have an 11-amino acid 
ssrA tag at the C terminus9. The ssrA tag is recognized by SspB, an adaptor protein that also binds to ClpX10–12. 
The interaction of SspB both with the ssrA tag and with ClpX enhances substrate recognition and improves deg-
radation at lower substrate concentrations10.
We are interested in establishing dynamic genetic circuits using a cell-free transcription-translation (TX-TL) 
system. To create dynamic genetic circuits, it is essential to have robust protein degradation in the TX-TL system 
to provide a constant flux of proteins. Although previous studies have used ClpXP to target specific regulatory and 
reporter proteins for degradation in vitro, these studies used simple buffers to test the activity of ClpXP or used 
the endogenous ClpXP in the TX-TL system3,4. In these latter studies, the amount of active ClpXP in cell extract is 
low, resulting in a low rate of protein degradation4. To overcome this problem, one study added the genes coding 
for ClpX and ClpP to the TX-TL system to increase the concentration of the ClpXP protease in cell extract, which 
resulted in improved degradation of the target proteins5. Nevertheless, adding known concentration of highly 
active, purified ClpXP to the TX-TL system would offer greater flexibility in the design and modeling of dynamic 
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gene circuits. Indeed a previous report showed that adding a purified, linked-hexameric version of ClpX to a 
TX-TL system increased the degradation of ssrA-tagged reporter proteins, indicating that this approach may be 
useful for creating dynamic gene circuits13.
Here we report the optimization of protein degradation in E. coli S30 cell extract-based TX-TL system by the 
ClpXP protease. To establish a protein degradation system that is highly active in the TX-TL system, we decided 
to use purified E. coli ClpXP protease. Our studies revealed that ClpXP activity is poor in the extract-based system 
because the concentration of ATP is low in the standard S30 cell extract used for TX-TL. Fortunately, adding ATP 
and an energy regeneration system significantly increased the activity of ClpXP in cell extract. We also demon-
strate that ClpXP is active in cell extract enclosed inside phospholipid vesicles, suggesting that our work could 
have future application in the development of artificial cells. By using radioactive ATP, we analyzed how ATP was 
consumed and converted to other adenine nucleotides in either reaction buffers or in the TX-TL system under 
different reaction conditions. Finally, we optimized the TX-TL system so that both protein synthesis and protein 
degradation could occur simultaneously and efficiently. Our results suggest that TX-TL systems supplemented 
with known concentrations of ClpXP and an energy regeneration system could be used to create synthetic genetic 
circuits that function in vesicles, enabling robust and predictable protein degradation in artificial cells.
Results
To establish the ClpXP protein degradation system, we overexpressed and purified C-terminal His-tagged ClpX, 
ClpP and SspB using E. coli (Fig. 1A). We also constructed a vector to overexpress and purify the N-terminal 
His-tagged superfolder EGFP that has the ssrA tag sequence at the C-terminus (sfEGFP-ssrA). We used 
sfEGFP-ssrA as the substrate for the ClpXP protein degradation system. The sfEGFP-ssrA protein was highly 
expressed in E. coli, and the yield after purification was about 30 mg per liter culture. We analyzed the activ-
ity of the purified ClpXP system to degrade sfEGFP-ssrA by measuring the fluorescence intensity (Fig. 1B). 
Additionally, we verified that the decrease in fluorescence intensity was due to protein degradation by ClpXP 
using SDS-PAGE (Supplementary Figure S1A). Steady-state kinetic parameters (kcat and KM) were determined 
in the PD buffer. The kcat for the degradation of sfEGFP-ssrA by ClpXP was 0.46 ± 0.01 min−1 in the presence of 
SspB and 0.50 ± 0.02 min−1 in the absence of SspB (Fig. 1C). The KM was 0.043 ± 0.007 μM in the presence of SspB 
and 0.52 ± 0.06 μM in the absence of SspB. Thus, SspB is important for protein degradation by ClpXP when the 
concentration of the protein substrate (sfEGFP-ssrA) is low. These results are consistent with previously published 
data10.
Previous studies showed that a linked hexameric version of ClpX is more active in protein degradation in vitro 
than the monomeric wild type ClpX13. We purified the linked hexameric version of ClpX and compared its activ-
ity to the monomeric ClpX. The degradation of sfEGFP-ssrA by the wild type ClpXP and the linked ClpXP was 
monitored. The linked ClpXP was slightly more active (initial rates are 38 nM min−1 and 30 nM min−1, respec-
tively) than the wild type ClpXP (Fig. 1D). However, we decided to optimize the activity of the wild type ClpXP 
because the yield of the purified linked ClpXP was very low.
We also examined the macromolecular crowding effects on the proteolytic activity of ClpXP. Studies have 
shown that macromolecular crowders generally stimulate biochemical reactions14–16, and hence 2% PEG-8000 is a 
standard component in TX-TL system. Here we added two commonly used macromolecular crowders, Ficoll-70 
and PEG-8000 up to 10% w/w to ClpXP reactions. Protein degradation by ClpXP was not affected by a low con-
centration of crowders but higher concentrations (larger than about 4%) decreased ClpXP activity (Fig. 1E,F). 
It is possible that the crowded environment stabilizes sfEGFP-ssrA protein and slows down the unfolding pro-
cess, which is the ATP-consuming step in ClpXP-dependent protein degradation. This may explain the inhibi-
tion of ClpXP activity at high concentrations of macromolecular crowders. Alternatively, high concentrations 
of crowders may cause protein precipitation or non-specific binding of proteins to the crowders resulting in the 
lowered ClpXP activity16. Nevertheless, we confirmed that 2% PEG-8000 present in TX-TL system won’t affect 
the performance of ClpXP.
One of our long-term goals is to develop artificial cells that can execute dynamic genetic circuits. An essen-
tial feature for a dynamic genetic circuit is to have a sink to degrade the newly synthesized proteins without 
damaging the proteins required for TX-TL5. Targeted protein degradation could be achieved using the ClpXP 
protease. However, the E. coli S30 extract that we used for in vitro TX-TL has very low proteolytic activity from 
endogenous ClpXP and other proteases. (Fig. 2A). Increasing the concentration of purified ClpXP protease in the 
E. coli S30 extract led to only a modest increase in the degradation of sfEGFP-ssrA (Fig. 2B). We hypothesized 
that the energy in the system, 1.2 mM ATP and an energy regeneration system containing 30 mM phosphoe-
nolpyruvate (PEP) and 48 U/mL pyruvate kinase (PK), was insufficient and limited the proteolytic activity of 
ClpXP in the TX-TL system. To verify this, we added either (1) 8 mM ATP or (2) 8 mM ATP plus extra energy 
regeneration components (16 mM PEP and 16 U/mL PK), 90 minutes after degradation reactions were started. 
As a control, we added water or dCTP (to account for Mg2+ chelation by ATP) to identical reactions performed 
in parallel. Addition of ATP or ATP plus energy regeneration components greatly stimulated the degradation of 
sfEGFP-ssrA and the reactions went nearly to completion (Fig. 2C). These results showed that the concentration 
of ATP in the S30 cell extract must be increased for optimal ClpXP activity. E. coli cell extract contains some 
endogenous ClpX and ClpP13, so we next examined the amounts of additional ClpX and ClpP needed for opti-
mal activity. Our results showed that degradation of 10 μM sfEGFP-ssrA was efficient with extra 300 nM ClpX 
and extra 100–300 nM ClpP in the presence of premix 4 (final concentration of ATP, PEP, and PK was 9.2 mM, 
41 mM, and 58 U/ml respectively) in the TX-TL system. The proteolytic activity was mainly limited by ClpX 
concentration but additional ClpP was required to speed up protein degradation when 300 nM ClpX was used17, 
suggesting that there’s more endogenous ClpP than ClpX (Supplementary Figure S1C,D). To further improve 
the activity of ClpXP in the cell-free expression systems, we added the energy regeneration system and titrated 
the concentration of ATP in the degradation reaction. Our studies showed that the S30 extract with 9.2 mM 
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Figure 1. Degradation of sfEGFP-ssrA by ClpXP in buffer. (A) SDS-PAGE showing the purified E. coli ClpX, ClpP, 
SspB, and sfEGFP-ssrA proteins. (B) Degradation of sfEGFP-ssrA by ClpXP in the presence (squares) or in the 
absence (circles) of SspB performed in the PD buffer. The concentration of sfEGFP-ssrA was either 1 μM (red) or 
10 μM (blue), and the concentration of ClpXP was 300 nM. No ClpXP was added to control reactions done in parallel 
(diamonds). (C) Measurement of steady-state kinetic parameters (kcat and KM). The initial rate of protein degradation 
per ClpXP molecule at different sfEGFP-ssrA concentration was used to determine the kinetic parameters. The kcat 
for ClpXP degradation of sfEGFP-ssrA is 0.46 ± 0.01 min−1 in the presence of SspB (square) and 0.50 ± 0.02 min−1 
in the absence of SspB (circle). The KM is 0.04 ± 0.007 μM in the presence of SspB and 0.52 ± 0.05 μM in the absence 
of SspB. (D) Protein degradation by the wild type ClpX (blue) and the linked-hexameric version (red) of ClpX6. The 
degradation of 1 μM sfEGFP-ssrA by 100 nM of each version of ClpXP. No ClpXP was added to the control reaction 
done in parallel (black). (E) Crowding effect of Ficoll-70 on ClpXP degradation. 1 μM sfEGFP-ssrA were degraded 
by 100 nM ClpXP in the presence of 0 to 10% w/w of crowding agent. (F) Crowding effect of PEG-8000 on ClpXP 
degradation. 1 μM sfEGFP-ssrA were degraded by 100 nM ClpXP in the presence of 0 to 10% w/w of crowding agent. 
The error bars show the standard deviation from at least three independent experiments. Plots without error bars are 
representative of at least three repeated experiments.
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ATP, 41 mM PEP and 58 U/mL PK resulted in efficient degradation of sfEGFP-ssrA by ClpXP (Fig. 2D). We also 
verified that the decrease in fluorescence intensity was due to protein degradation by ClpXP using Western blot 
(Supplementary Figure S1B). It’s also worth noting that although degradation was efficient and almost complete, 
it was still slower than in buffer control. Finally, all premixes were tested without adding purified ClpXP to serve 
as negative controls and see if they were activating the endogenous ClpXP. The results with different premixes 
but no ClpXP added were similar, which indicated that additional energy components won’t activate endogenous 
ClpXP significantly.
Since one of our long-terms goals is to reconstitute genetic circuits in artificial cells, we tested the degra-
dation of sfEGFP-ssrA by ClpXP in lipid bound vesicles. The lipid used to form vesicles was 1-palmitoyl-2
-oleoyl-sn-glycero-3-phosphocholine (POPC) and vesicles were formed by the inverse-emulsion method18–20. 
The vesicles contained S30 extract with 10 μM sfEGFP-ssrA and 200 nM ClpXP. Degradation of sfEGFP-ssrA 
was monitored by fluorescence imaging using a spinning disk confocal microscope. ClpXP completely degraded 
Figure 2. Optimization of ClpXP degradation in the TX-TL system. (A) ClpXP activity in the TX-TL system. 
The degradation of 1 μM (red) and 10 μM (blue) sfEGFP-ssrA by 100 nM extra ClpXP added to the complete 
TX-TL system (square) or by the endogenous ClpXP present in the TX-TL system (circle). In (B), (C) and (D) 
a positive control reaction was performed with 300 nM ClpXP and 10 µM sfEGFP-ssrA in premix 1 (red). (B) 
The degradation of sfEGFP-ssrA at different concentrations of ClpXP in the TX-TL system. 10 μM sfEGFP-ssrA 
were degraded by 0 nM (black), 100 nM (magenta), 200 nM (blue), or 300 nM (green) of ClpXP. (C) Analyzing 
the effect of increasing the ATP concentration on protein degradation by the wild type ClpXP in the TX-TL 
system. The degradation of 10 μM sfEGFP-ssrA by 0 nM (black), or 300 nM of ClpXP. After the degradation 
reactions were incubated for 1.5 hour, either 1 µL of water (magenta), 8 mM dCTP (green), 8 mM ATP (blue) or 
8 mM ATP, 16 mM PEP, and 16 U/mL pyruvate kinase (indicated as ER) (orange) solution was added at the time 
point shown by the arrow. 1 µL of water was also added in negative control reaction (black) at the same time 
point. (D) Optimization of protein degradation by the wild type ClpXP in the TX-TL system. The degradation 
of 10 μM sfEGFP-ssrA by 300 nM ClpXP at different concentrations of ATP and in the presence of energy 
regeneration system. The standard TX-TL system with premix1 (yellow), premix 2 (orange), premix 3 (green), 
or premix 4 (blue). Control reactions were performed without ClpXP with premix 1 (black) and premix 2 
(grey). Positive control reaction (red) was the degradation of 10 μM sfEGFP-ssrA with 300 nM ClpXP in premix 
1 without cell extract. The final concentrations of ATP is 1.2 mM in premix 1, 21.2 mM in premix 2, 5.2 mM ATP 
in premix 3, and 9.2 mM in premix 4. Data are representative of at least three repeated experiments.
www.nature.com/scientificreports/
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sfEGFP-ssrA in about 2 hours, demonstrating that ClpXP was still very active in the vesicles (Fig. 3A,B). This is an 
important first step for building dynamic genetic circuits in vesicles.
Another essential feature to enable a dynamic genetic circuit is for the synthesis of target proteins simul-
taneous to protein degradation. This requires that conditions must be optimized for both protein degradation 
and protein synthesis. Therefore, we tested the efficiency of TX-TL under the optimized ClpXP degradation 
condition. The reporter protein synthesized is deGFP, an N-terminal truncated, C-terminal modified version of 
enhanced green fluorescent protein (eGFP), which has been shown to have better expression yield in TX-TL21. 
Unfortunately, TX-TL of deGFP was almost fully inhibited in the optimized condition for ClpXP degradation 
(Fig. 3C). We tested whether degradation by ClpXP could occur at conditions that were more similar to the 
TX-TL reaction by titrating the concentration of ATP, and presence or absence of PEP and PK (Supplementary 
Figure S2A,B). These experiments showed that efficient degradation of 10 µM sfEGFP-ssrA by ClpXP occurs 
when an additional 4–8 mM ATP is added (Supplementary Figure S2A). Additionally, it is not essential to add 
extra PEP or PK to the ClpXP degradation reaction because they are present in sufficient concentrations in the 
premix buffer (Supplementary Figure S2B). Thus, protein degradation by ClpXP in the S30 extract was efficient if 
the concentration of ATP is 7.2–9.2 mM (premix 1 has 1.2 mM ATP and we added extra 6–8 mM ATP).
In contrast, the TX-TL reaction normally has 1.2 mM ATP, and 7.2–9.2 mM ATP inhibits the reaction. We 
reasoned that the extra ATP that we added to improve the activity of ClpXP was chelating Mg2+ thereby lowering 
the concentration of free Mg2+ causing the inhibition of TX-TL. Indeed, a recent study showed that nearly half of 
the Mg2+ in the cell is chelated by nucleotides22. We tested whether TX-TL activity could be restored by adding 
extra Mg2+. Increasing the concentration of Mg2+ resulted only in a modest 30% increase in TX-TL compared 
to the control reaction without extra Mg2+ (Supplementary Figure S3A). We titrated the concentration of ATP, 
Mg2+, PEP, and PK to further optimize the TX-TL reaction (Supplementary Figure S3B–F). We also showed 
that the polyamines, such as spermine, putrescine, and spermidine, could partly substitute for the Mg2+ in the 
TX-TL reaction (Supplementary Figure S4). The addition of an extra 5 mM Mg-glutamate (final Mg2+ concentra-
tion is 19.2 mM), or 0.5 mM spermine and 1 mM Mg-glutamate, or 2 mM spermidine and 1 mM Mg-glutamate 
increased the activity of the TX-TL reaction to ~70% of the maximum. (Fig. 3D). ClpXP was stored in buffer 
supplemented with 10% glycerol. Therefore, the optimized TX-TL reaction has 2.5% final glycerol concentra-
tion, which could be responsible for the ~30% inhibition in gene expression (Supplementary Figures S5A,B). 
The optimized conditions (with extra 6 mM ATP and 5 mM Mg-glutamate) were then used to test the activity of 
ClpXP again. ClpXP activity was slightly slowed by the addition of extra 5 mM Mg-Glutamate (Fig. 3E). Thus, 
we established new optimized conditions (7.2 mM ATP and 19.2 mM Mg2+ final concentrations) in which both 
the TX-TL reaction and protein degradation by ClpXP can occur simultaneously, although it is not the most 
efficient condition for each individual reaction. The optimized conditions were used to test whether the synthesis 
of deGFP and the degradation of mCherry-ssrA by ClpXP could occur simultaneously. As shown in Fig. 3F, we 
observed the efficient synthesis of deGFP and the degradation of mCherry-ssrA in the same reaction confirming 
that the optimized conditions are suitable for the design and testing of gene circuits in vitro.
To better understand why the same energy regeneration system and ATP concentration, which was enough 
to saturate 300 nM ClpXP (Supplementary Figure S1E), gave us very different ClpXP activity in buffers and the 
TX-TL systems, we established an ATP consumption assay using PEI-cellulose TLC to monitor the concen-
trations of [α-32P]-ATP and its hydrolyzed products (Fig. 4A). The degradation of sfEGFP-ssrA by ClpXP was 
performed in the presence of [α-32P]-ATP and the degradation reaction was continuously monitored by the 
decrease in the fluorescence intensity of sfEGFP-ssrA. In parallel, an aliquot of the degradation reaction was 
used to monitor ATP consumption at fixed time points. As a control reaction, we used ClpXP with premix 1, 
which shows zero-order-like reaction kinetics for protein degradation, and a stable level of ATP concentration 
(Fig. 4B), demonstrating that the energy regeneration system can maintain the ATP concentration. When we used 
premix 1 without any PK, the enzyme responsible for regenerating ATP by transferring a phosphate group from 
PEP to ADP, protein degradation slowed down quickly, and ATP concentration decreased as ADP concentration 
increased. This result shows that the stable level of ATP in the reaction with premix 1 is maintained by the ATP 
regeneration mechanism of PK (Supplementary Figure S5C). Thus, ClpXP is very active in premix 1 which has 
1.2 mM ATP and an efficient energy regeneration system with 25 mM PEP and 42 U/mL PK.
However, one of the problems we encountered originally is that the activity of ClpXP decreases drastically 
in the TX-TL system. We discovered that ATP was consumed rapidly in the TX-TL system, and simultaneously 
high levels of AMP accumulated (Fig. 4C and Supplementary Figure S5D). This behavior was not observed in 
the buffer systems (Fig. 4B and Supplementary Figure S5C). Even with the creatine kinase-phosphocreatine 
energy regeneration system, ATP was consumed quickly, while AMP accumulated to high levels (Supplementary 
Figure S5E). In the improved system with premix 4 (extra 8 mM ATP, 16 mM PEP, 16 U/mL PK were added, and 
final concentrations are 9.2 mM ATP, 41 mM PEP, and 58 U/mL PK), we can see that ATP concentration went 
down in the first hour and then reached a steady-state level concentration of about 4 mM (Fig. 4D) while ADP 
concentration also reached a steady-state level, and sfEGFP-ssrA is degraded at a reasonably rapid rate. ATP 
concentration went down again after two hours as AMP concentration went up. Interestingly, byproducts from 
ATP hydrolysis, such as AMP, inorganic phosphate, and pyrophosphate, do not inhibit ClpXP (Supplementary 
Figure S6A–C), but the concentration of ADP or the [ATP]/[ADP] ratio are more important for optimal activity 
in the buffer system (Supplementary Figure S6E). Finally, we found that more than 50% of the ATP was consumed 
in the first hour in cell extract even without the addition of exogenous ClpXP (Fig. 4E). Our results demonstrate 
that ATP is mostly consumed by enzymes present in the E. coli S30 cell extract. Therefore, for optimal degrada-
tion of proteins by ClpXP in the TX-TL system, the steady-state concentration of ATP must be maintained high 
enough by adding more ATP or a more efficient energy regeneration system.
www.nature.com/scientificreports/
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Figure 3. Degradation of sfEGFP-ssrA in vesicles by ClpXP and optimizing both TX-TL and ClpXP activity. 
(A) Fluorescence images of sfEGFP-ssrA degradation in a representive vesicle at 0, 20, 40, 60, 80, 100, 
120 minutes. The degradation of 10 μM sfEGFP-ssrA in the TX-TL cell extract with 200 nM ClpXP added 
(top), or no ClpXP added (bottom) are shown. The scale bars represent 10 µm. (B) Time course of ClpXP 
degradation in vesicles. The degradation kinetics of sfEGFP-ssrA in the presence (red) or absence of ClpXP 
(black) in vesicles. The degradation kinetics of at least 10 vesicles were measured to calculate the standard 
deviations. (C) Protein synthesis in the optimized condition for ClpXP activity. Reactions were performed in 
TX-TL systems containing premix 1 (red) or premix 4 (black). (D) Effects of Mg2+ and polyamines on TX-TL 
reactions. Reactions were performed under standard condition with premix 5 and additional Mg-glutamate 
and/or polyamines: 5 mM Mg-glutamate (green); 2 mM spermidine and 1 mM Mg-glutamate (orange); 0.5 mM 
spermine and 1 mM Mg-glutamate (magenta); 8 mM putrescine and 1 mM Mg-glutamate (blue). Control 
reactions were performed with premix 1 (red) and premix 5 (black). (E) Effect of additional Mg2+ on ClpXP 
activity in TX-TL systems. Control reaction (black) was performed in premix 1. Premix 5 was used for all the 
other reactions. The extra Mg-glutamate added to the reactions were: 0 mM (orange), 2.5 mM (blue), 5 mM 
(red), and 7.5 mM (green). (F) Simultaneous protein synthesis and degradation in the TX-TL system. All the 
reactions were performed under standard condition with premix 5 and extra 5 mM Mg-glutamate. Control 
reactions for protein degradation were performed with 500 nM mCherry-ssrA without ClpXP (pink triangles) 
www.nature.com/scientificreports/
7Scientific REPORTS |  (2018) 8:3488  | DOI:10.1038/s41598-018-21739-6
Discussion
Protein degradation plays a key role for controlling gene expression by removing regulatory proteins that are no 
longer needed by the cell. Studies have shown that protein degradation is also important for spatially and tem-
porally coupling synthetic genetic circuits in cells23,24. However, the activity of the endogenous proteases in cell 
extract is low and insufficient to build dynamic in vitro genetic circuits.
In a previous study, purified ClpXP was used to degrade ssrA-tagged eGFP in bulk and in vesicles, but the 
reaction was performed in a simple buffer3. In another study, the degradation rate by the endogenous ClpXP 
present in the E. coli S30 extract was analyzed with 1 µM of deGFP-ssrA substrate4. The rate of degradation by the 
endogenous ClpXP was slow (vo = 10 nM min−1) and inadequate to create dynamic genetic circuits. To overcome 
this shortcoming, a subsequent study cloned the clpP-clpX genes from E. coli into a vector under the P70a pro-
moter5. The vector was added at different concentrations to the TX-TL cell extract and preincubated to produce 
ClpX and ClpP proteins. Then eGFP-ssrA protein was added as a substrate and the reaction was monitored. A 
high rate of protein degradation was observed with 6 nM plasmid and 5 µM eGFP-ssrA. Thus, the low activity of 
the endogenous ClpXP was overcome by synthesizing ClpXP in the TX-TL system, and this approach could be 
used to create simple gene circuits in vitro5.
However, synthesizing ClpXP from vectors by the TX-TL system has some disadvantages. First, determining 
the precise concentration of ClpXP in the reaction will require additional experiments. Second, the production 
of ClpXP in parallel by the TX-TL system may interfere with the function of complex genetic circuits. Therefore, 
we decided to purify the E. coli ClpXP protease and test its activity in a TX-TL cell extract. Consistent with pre-
vious studies, the activity of the purified ClpXP was high in the PD buffer but was very low when added to the 
standard S30 cell extract used for TX-TL3,4. Our results show that the low activity of the purified ClpXP is due to 
the low steady-state concentration of ATP in the E. coli S30 cell extract used for TX-TL, which has 1.2 mM ATP 
and an energy regeneration system (25 mM PEP and 42 U/mL PK) for supporting efficient protein synthesis. 
Importantly, increasing the final concentration of ATP to 9.2 mM, PEP to 41 mM, and PK to 58 U/mL in the 
TX-TL significantly improved the activity of the purified ClpXP. The degradation of sfEGFP-ssrA in the S30 cell 
extract went to completion under the optimized reaction conditions. This indicates that protein degradation by 
ClpXP consumes lots of ATP and the steady-state level of ATP in the cell extract is insufficient to support robust 
protein degradation. Indeed, previous studies have shown that ClpXP hydrolyzes about 600 ATPs to degrade 
one molecule of the I27 domain of human titin (121 residues)25. We also show that ClpXP is active in cell extract 
inside vesicles. The rate of sfEGFP-ssrA degradation by ClpXP in vesicles is similar to the rate observed in bulk 
indicating that vesicles containing cell extract optimized for gene expression and protein degradation could be 
used to create artificial cells that execute dynamic genetic circuits.
We analyzed how energy consumption and regeneration affect the activity of ClpXP. First, we showed that our 
energy regeneration system using PEP/PK is efficient that we can even use ADP as the initial energy molecule 
(Supplementary Figure S6D). We also confirmed that AMP and other byproducts do not directly inhibit ClpXP. 
So the correlation between the accumulation of AMP and the lower activity of ClpXP could be accounted by 
the decreasing total amount of energy molecules, including both ATP (for reaction) and ADP (for regenerat-
ing ATP). The accumulation of AMP is probably due to some enzymes in the cell extract, e.g. adenylate kinase, 
ADP-dependent NAD(P)HX dehydratase, and aminoacyl tRNA synthetases. Inhibiting these enzymes or finding 
a way to regenerate ATP or ADP from AMP could potentially help ClpXP to work better in the extract-based 
cell-free systems26,27.
Moreover, we noticed that the steady-state level of ATP concentration in the optimized conditions (Fig. 4D) 
was about 4 mM in the TX-TL system; however, the rates of protein degradation by ClpXP were slower compared 
to the reaction with 1.2 mM ATP in the premix buffer (Fig. 4B). This suggests that ATP concentration is not the 
only factor to affect the activity of ClpXP in our cell-free systems. Additional experiments showed that the rates 
of protein degradation by ClpXP decreased when we added higher concentration of ADP to achieve lower [ATP]/
[ADP] ratio in the buffer without energy regeneration system (Supplementary Figure S6E). This is because pro-
tein degradation by ClpXP is mainly powered by the ATPase domains on the ClpX subunit and changes in the 
[ATP]/[ADP] ratio is expected to affect the activity of ClpXP significantly.
Our studies showed that protein degradation by ClpXP in the S30 extract needs a higher concentration of 
ATP than is optimal for the TX-TL reaction. We systematically optimized the concentration of ATP, Mg2+, PK, 
and PEP to identify a new condition that is optimal for both ClpXP activity and the TX-TL reaction. The new 
optimized condition is 7.2 mM ATP, 19.2 mM Mg2+, 25 mM PEP, and 42 U/mL PK. We used the optimized con-
dition to successfully carry out simultaneous synthesis of deGFP and the degradation of mCherry-ssrA by ClpXP. 
Although the new conditions are not optimal for the individual reactions, we have identified conditions where the 
activity of ClpXP and the TX-TL reaction can be altered easily by changing the steady-state concentration of ATP 
or Mg2+. Our results implicate that to establish dynamic genetic circuits containing multiple energy consuming 
biochemical reactions, such as protein synthesis or protein degradation by AAA+ proteases, the supply and turn-
over of energy molecules should be accounted with care. We showed that it’s possible to achieve high efficiency 
in both protein synthesis and protein degradation in extract-based cell-free systems. More complicated dynamic 
genetic circuits could be optimized based on the same principle, and we believe that the ability to modulate the 
rates of protein synthesis and protein degradation will be very useful for fine tuning the performance of in vitro 
genetic circuits.
or with 300 nM ClpXP (pink diamonds); TX-TL reaction control for deGFP synthesis was performed in the 
absence of mCherry-ssrA and ClpXP (green squares); combined reactions included degradation of 500 nM 
mCherry-ssrA by 300 nM ClpXP (pink circles) and deGFP synthesis (green circles). Data are representative of at 
least three repeated experiments.
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Methods
Cloning and protein purification. E. coli clpX, clpP, and sspB genes were subcloned in pMCSG26 vector 
with C-terminal His-tag. sfEGFP-ssrA and mCherry-ssrA were subcloned in pMCSG7 vector with N-terminal 
His-tag. Plasmid pACYC-FLAG-dN6-His encoding ClpX linked hexamer version was from Addgene (# 22143). 
E. coli BL21 (DE3) cells were used to overexpress and purify all proteins. Cells were grown at 37 °C to A600 0.5–0.8, 
Figure 4. ATP consumption and protein degradation by ClpXP. (A) A representative phosphor image of ATP 
consumption assay by ClpXP in the TX-TL system with additional 8 mM ATP, 16 mM phosphoenolpyruvate, and 
16 U/mL pyruvate kinase. Samples were collected and quenched at 1, 5, 10, 20, 30, 45, 60, 90, 120, and 180 minutes 
after the reaction started. ATP, ADP, and AMP were separated on a PEI-cellulose TLC plate and quantified with a 
phosphor imager. The dark spots correspond to radioactive ATP, ADP, and AMP, respectively, from bottom to top. 
Spots were quantified and normalized by each lane and the ratio of each adenosine phosphate species were plotted. 
(B–E) are graphs showing protein degradation and ATP consumption. All reactions were performed with 300 nM 
ClpXP (except in (E)) and 10 µM sfEGFP-ssrA in different conditions for 3 hours. (B) The reaction was performed 
in premix 1. (C) The reaction was performed in the TX-TL system with premix 1. (D) The reaction was performed 
in the TX-TL system with premix 4. (E) The reaction was performed without ClpXP in the TX-TL system with 
premix 4. Data are representative of at least three repeated experiments.
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chilled to 18 °C for ClpX, chilled to 30 °C for ClpP and SspB, chilled to 37 °C for sfEGFP-ssrA and mCherry-ssrA. 
Protein overexpression was induced with 1 mM IPTG and the cells were grown for another 3–4 hours. The cells 
were lysed using a French press at 18000 psi and the proteins purified by Ni-NTA affinity chromatography as pre-
viously described28,29. Purified ClpP, and SspB proteins were dialyzed against storage buffer (50 mM Tris-HCl, pH 
7.5, 200 mM KCl, 25 mM MgCl2, 1 mM DTT, 10% Glycerol). ClpX was purified further using a Superdex 75 16/60 
column equilibrated in the above storage buffer. The concentrations of ClpX6, ClpP14, and SspB2 were 1.4 μM 
(hexamer), 12 μM(tetradecamer), 57 μM(dimer), respectively. sfEGFP-ssrA was dialyzed against buffer (20 mM 
K-Hepes, pH 7.5). mCherry-ssrA were stored in buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl. The 
concentrations of sfEGFP-ssrA and mCherry-ssrA were 120 μM and 125 μM, respectively. ClpX linked hexamer 
protein was purified by Ni-NTA affinity chromatography and further purified using a Superdex 200 16/60 size 
exclusion column (GE Healthcare) and stored in the buffer containing 50 mM Tris-HCl, pH7.6, 300 mM NaCl, 
1 mM DTT, 10% glycerol. The concentration of the linked ClpX6 was 3 μM. Protein concentrations were measured 
using Bradford method. All proteins were stored at −80 °C.
Fluorescent protein measurement and quantification. The fluorescence of sfEGFP-ssrA or deGFP 
was measured by using Tecan GENios microplate reader (excitation filter wavelength (band width): excita-
tion filter 485 (20) nm; emission filter wavelength (band width): 535 (25) nm; gain 45) unless stated otherwise. 
Fluorescence intensity was transformed into concentration unit using a standard curve made with our purified 
sfEGFP-ssrA. Data was analyzed and graphs were created by Graphpad Prism software. All TX-TL and degrada-
tion reactions were performed at 30 °C.
In vitro protein degradation assay. Degradation assay of sfEGFP-ssrA by ClpXP was performed with 
10 µL reaction volume in PD buffer (25 mM K-Hepes, pH 7.6, 200 mM KCl, 5 mM MgCl2, 0.032% Nonidet P-40, 
and 10% glycerol) with an energy regeneration system (4 mM ATP, 16 U/mL creatine kinase, and 16 mM creatine 
phosphate). If SspB was used, the concentration of SspB was the same as sfEGFP-ssrA and SspB was pre-incubated 
with sfEGFP-ssrA for the degradation assay. 100 nM ClpXP (ClpX6:ClpP14 = 1:3) and 1 µM sfEGFP-ssrA was used 
for most degradation assay in PD buffer because we could analyze the function of SspB in the reaction and easily 
follow the time course of the reaction. Adenosine nucleotides, phosphates, and pyrophosphates were prepared as 
100 mM stock solution at pH 7.0 and added separately to desired concentration. Adenosine 5′-monophosphate 
sodium salt (AMP, prod# A1752), adenosine 5′-diphosphate monopotassium salt dehydrate (ADP, prod# A5285), 
and sodium pyrophosphate decahydrate (PPi, prod# 221368) were purchased from Sigma Aldrich, and 85% phos-
phoric acid was purchased from Macron Chemicals (prod# 2796–05). The effect of ADP and AMP on ClpXP 
activity were analyzed in premix 1. Fluorescence of sfEGFP-ssrA was monitored by microplate reader. 10 µM 
sfEGFP-ssrA degradation by 300 nM ClpXP was analyzed using SDS-PAGE.
kcat and KM measurement. kcat and KM measurement was performed in PD buffer by combining 50 nM 
ClpXP with varied concentration of sfEGFP-ssrA. Degradation rates were calculated from the initial linear loss 
of fluorescence. Curve fitting was performed using the Michaelis-Menten equation built in Graphpad Prism soft-
ware. The experiment was repeated two times.
Macromolecular crowding effect on ClpXP activity. Degradation were performed in PD buffer system 
with 1 µM sfEGFP-ssrA, 100 nM ClpXP, and various crowders, including up to 20% w/w PEG-400, PEG-8000, 
PEG-20000, Ficoll-70, and Ficoll-400. Reactions were performed in 10 µL of volume on a 384-well plate and flu-
orescence of sfEGFP-ssrA was monitored by using microplate reader.
Optimization of ClpXP activity in cell extract. E. coli Rosetta 2 (DE3) cell extract was prepared as 
described previously30 with minor modifications. Briefly, 1 g of cells were resuspended in 1.1 mL of S30A buffer. 
The cells were lysed by passing it twice through a French Press at 18000 psi. The extract was clarified by centrif-
ugation at 12000 g for 10 min. The clear supernatant was preincubated at 37 °C for 80 min and the extract was 
clarified again at 12000 g for 10 min. The clear supernatant was dialyzed against 1 L of S30B buffer containing 60 
mM K-glutamate and 14 mM Mg-glutamate for 3 hours. The extract was clarified at 12000 g for 10 min and was 
stored as small aliquots at −80 °C. Degradation reactions were performed in 12 µL final volume consisting of 
4 µL cell extract (final protein concentration is 7.5–8 mg/mL), 3 µL ClpXP (final concentration 300 nM) or buffer 
contains 25 mM MgCl2 and 200 mM KCl, 1 µL sfEGFP-ssrA (at different concentrations), 4 µL premix 1 [42 mM 
K-Hepes, pH 8.2, 0.7 mM CTP and UTP, 1.2 mM GTP and ATP, 25 mM phosphoenol pyruvate (PEP), 42 U/
mL pyruvate kinase (PK), 2.5 mM of 20 amino acid, 1.7% PEG-8000, 0.057 mM folinic acid, 0.17 mg/mL tRNA, 
0.8 mM putrescine, 8 mM Magnesium glutamate, 120 mM potassium glutamate, all at final concentrations]30. 
The ClpX6 to ClpP14 ratio was 1:1 in the reactions with cell extract and 1:1.3 in the reactions without cell extract. 
Additionally, the ClpXP degradation in cell extract was optimized by increasing the concentration of ATP, PEP 
and PK as follows: premix 2 (extra 20 mM ATP was added, and final ATP concentration is 21.2 mM), premix 3 
(extra 4 mM ATP, 16 mM PEP, 16 U/mL PK were added, and final concentrations are 5.2 mM ATP, 41 mM PEP 
and 58 U/mL PK), and premix 4 (extra 8 mM ATP, 16 mM PEP, 16 U/mL PK were added, and final concentrations 
are 9.2 mM ATP, 41 mM PEP and 58 U/mL PK). Premix 5 (extra 6 mM ATP was added to premix 1. The final 
ATP concentration is 7.2 mM). The differences in the concentrations of ATP, PEP, PK, and Mg2+ in the premixes 
are shown in Table S1. 10 µM sfEGFP-ssrA degradation by 300 nM ClpXP was analyzed using Western blot with 
anti-His tag antibody purchased from Thermo Scientific (Cat# MA1-21315).
In vitro Transcription-Translation (TX-TL) of deGFP. Standard TX-TL reactions were composed of 4 µL 
S30 extract (final protein concentration is 7.5–8 mg/mL), 1 µL pBEST-deGFP plasmid (Addgene plasmid# 40019, 
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final concentration is 8.3 nM), 4 µL premix 1 (final concentration of ATP is 1.2 mM), and 3 µL of ClpXP storage 
buffer (which contributes 50 mM KCl, 6.2 mM MgCl2 and 2.5% glycerol to the final reaction). Reactions were 
performed in 12 µL of volume on a 384-well plate and fluorescence of deGFP was monitored by microplate reader.
Optimization of TX-TL system under ClpXP degradation condition. Optimization of TX-TL system 
under the ClpXP degradation condition were performed in the presence of premix 5 (final concentration of ATP 
is 7.2 mM). Extra Mg-Glutamate or polyamines were added to restore the activity. Reactions were performed in 
12 µL volume containing of 4 µL cell extract (final concentration of protein is 7.5–8 mg/mL), 4 µL premix 5 (final 
concentration of ATP is 7.2 mM), and 1 µL pBEST-deGFP plasmid (final concentration is 8.3 nM), 3 µL of ClpXP 
storage buffer (which contributes 50 mM KCl and 6.2 mM MgCl2 to the final reaction), and extra Mg2+ and/or 
polyamines.
ClpXP proteolytic activity under optimized TX-TL condition. ClpXP reactions were performed in 
12 µL final volume consisting of 4 µL cell extract (final protein concentration is 7.5–8 mg/mL), 4 µL premix 5 
(final concentration of ATP is 7.2 mM), 3 µL ClpXP (final concentration 300 nM) and magnesium glutamate (at 
different concentration), 1 µL sfEGFP-ssrA (final concentration is 10 µM).
Simultaneous protein synthesis and degradation in TX-TL systems. Protein synthesis and ClpXP 
reactions were performed in 12 µL final volume consisting of 4 µL cell extract (final protein concentration is 
7.5–8 mg/mL), 4 µL premix 5 with pBEST-deGFP plasmid (final concentrations are: 7.2 mM ATP, 19.2 mM Mg2+ 
and 5 nM plasmid), 3 µL ClpXP (final concentration 300 nM), and 1 µL mCherry-ssrA (final concentration is 
0.5 µM). Reactions were performed at 30 °C on a 384-well plate and the fluorescence of deGFP (excitation filter 
wavelength (band width): 485 (20) nm, emission filter wavelength (band width): 535 (25) nm) and mCherry-ssrA 
(excitation filter wavelength (band width): 560 (10) nm and emission filter wavelength (band width): 612 (20) 
nm) were simultaneously monitored by using Tecan Infinite F200 microplate reader.
ATP consumption assay. This method was modified from Rajagopal and Lorsch’s protocol of ATP and 
GTP Hydrolysis Assay (TLC)31. PEI-cellulose TLC plate was cut to the appropriate size, pre-developed completely 
with water, and then dried. After setting up reactions with [α-32P]-ATP, 3 µL reaction solution was taken out and 
mixed with 3 µL quenching solution (1 M HCOOH) at different time points. In addition, 9 µL reaction solution 
of each sample was taken out right after mixing and transferred to a 384-well plate for parallel measurement 
of protein degradation. When samples from all time points were collected, 1 µL of each quenched sample was 
spotted on the marked places on the plate, and air dried. The TLC plate was developed with 0.5 M K2HPO4, pH 
3.5, for 25 min, then dried. The TLC plate was wrapped in a clear plastic wrap, and exposed to a storage phosphor 
screen (Amersham Bioscience). The screen was then scanned with Bio-Rad Personal Molecular Imager™ (PMI™) 
System or GE Healthcare Life Sciences Typhoon FLA 9500, and the data was analyzed with the Bio-Rad Quantity 
One® or ImageJ software.
Vesicle preparation. Vesicles were prepared with POPC (1-palmitoyl-2-oleoyl-sn-glycero-
3-phophocholine) purchased from Avanti Inc. (cat# 850457 P) as described previously18–20. To prepare the lipid 
suspension for the inner leaflet, POPC was first dissolved in chloroform, and the chloroform was subsequently 
evaporated with dry nitrogen in the hood affording a lipid film. The POPC film was then re-dissolved in heavy 
mineral oil (Fisher Scientific cat# O122-1) at 5 mg/mL, heated at 50 °C, and sonicated for one hour in a water 
bath to evenly distribute the lipid. 10 μL of degradation reaction (described in next section) was added to 100 µL 
of POPC oil and vigorously mixed until it was a cloudy emulsion formed. The emulsion was then layered over 
100 µL of 0.5 M Tris-HCl, pH 7.5, centrifuged for 10 min at 9000 rcf at room temperature. The bilayer vesicles 
were formed as they passed through the water/oil phase and pelleted at the bottom. Oil and some buffer were 
discarded, and the vesicles were resuspended in the rest of buffer.
Degradation assay in vesicles. Degradation reaction was prepared by mixing 200 nM ClpXP and 10 μM 
sfEGFP-ssrA in optimized TX-TL system (plus extra 8 mM ATP, 16 mM phosphoenolpyruvate, and 16 U/mL 
pyruvate kinase). Vesicles were then prepared via the inverse emulsion method using the degradation reac-
tion mixture as previously described. 10 µL of the resulting vesicle solution was added to a glass microscope 
slide and covered with a glass coverslip supported with vacuum grease. Fluorescence microscope images were 
acquired on a Yokagawa spinning disk system (Yokagawa, Japan) built around an Axio Observer Z1 motorized 
inverted microscope (Carl Zeiss Microscopy GmbH, Germany) with a 63×, 1.40 NA oil immersion objective to 
an ORCA-Flash 4.0 camera managed using Micromanager software. 10–20 vesicles were selected and pictures 
were taken every 10 min using a 488 nm, 100 mW OPSL laser, to excite the sfEGFP. Fluorescence intensity was 
quantified by using ImageJ software.
Data availability. The datasets generated and/or analyzed during the current study are available from the 
corresponding author on reasonable request.
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